Awards and Rankings September 26, 2018

22 Goodwin Partners Named ‘Life Sciences Stars’ by LMG Life Sciences

Twenty two Goodwin partners were named to LMG Life Sciences’ Stars list, recognized for being outstanding practitioners in the U.S.

The following four partners were included in the directory for the first time:

Additional partners named this year included:

  • Michael Bison (Financial & Corporate, Mergers & Acquisitions)
  • Mitchell Bloom (Licensing & Collaboration, Venture Capital, Corporate, Mergers & Acquisitions)
  • Kristopher Brown (Financial & Corporate, Corporate, Licensing & Collaboration, Mergers & Acquisitions, Venture Capital)
  • Stuart Cable (Financial & Corporate, Corporate, Mergers & Acquisitions)
  • Marta Delsignore (Hatch-Waxman Patent Litigation (Generic), Hatch-Waxman Patent Litigation)
  • Anthony Downs (Hatch-Waxman Patent Litigation (Generic), General Patent Litigation, Hatch-Waxman Patent Litigation)
  • Joanne Gray (Product Liability)
  • Duncan Greenhalgh (Patent Prosecution, Patent Strategy & Management)
  • David Hashmall (Hatch-Waxman Patent Litigation (Generic), Hatch-Waxman Patent Litigation)
  • Elizabeth Holland (Hatch-Waxman Patent Litigation (Generic), General Patent Litigation, Hatch-Waxman Patent Litigation)
  • Douglas Kline (Intellectual Property, General Patent Litigation)
  • Scott Lassman (FDA: Pharmaceutical, FDA: Medical Device, Healthcare Pricing & Reimbursement)
  • Frederick Rein (Hatch-Waxman Patent Litigation (Generic), Patent Strategy & Management, Hatch-Waxman Patent Litigation, General Patent Litigation)
  • Karen Spindler (Mergers & Acquisitions, Licensing & Collaboration)
  • Kingsley Taft (Licensing & Collaboration, Venture Capital, Corporate, Mergers & Acquisitions)
  • Julie Tibbets (FDA: Medical Device, FDA: Pharmaceutical)
  • Daryl Wiesen (Hatch-Waxman Patent Litigation (Generic), Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation)
  • Maggie Wong (Licensing & Collaboration, Venture Capital, Corporate, Mergers & Acquisitions)

LMG Life Sciences research involved over 1,000 online surveys and interviews with nearly 600 attorneys in the United States, as well as a review of public information and feedback from clients within the industry.